Company News

   

BSI’s Kilo-GMP Expansion in Rensselaer NY

Renovations are nearly completed on our new, 10,000 sq. ft. GMP Kilo Scale facility in Rensselaer NY. Paired with our R&D and non-GMP kilo scale labs, BSI is adding seven new Kilo Scale, small molecule synthetic and purification suites for the development and manufacture of small volume APIs and other critical small molecules used in the growing Bio Pharmaceutical market.  The first suites for GMP Kilo Scale will launch by end of year 2021!
BSI-Kilo_Scale-API Flyer.pdf

BioSpectra Launches New Product, 6M Urea GMP

BioSpectra is adding to its line of GMP products, a 6M Urea, Large Volume, GMP Solution, manufactured from multicompendial GMP urea and water for injections. This product will be manufactured in our new class 7 suite located in Bangor PA. Batch sizes are 7,000 liters.
Urea-6M-Excipient-UREA-3120.pdf

CPhI Worldwide, Milan Italy, Nov. 9-11, 2021

BioSpectra will be exhibiting in Europe at the global Pharmaceutical Show
CPhI Worldwide, hosted in Milan Italy this year.
CPHi-Milan-2021-Booth #5F15

COVID-19 Update from BioSpectra, Inc.

https://www.biospectra.us/covid-19-update-from-biospectra

BIOSPECTRA ANNOUNCES LAUNCH OF NEW CLASS 6 MANUFACTURING SUITE.

https://www.biospectra.us/biospectra-announces-launch-of-new-class-6-manufacturing-suite

BIOSPECTRA ANNOUNCES EXPANSION OF WAREHOUSE CAPABILITIES.

https://www.biospectra.us/biospectra-announces-expansion-of-warehouse-capabilities

BIOSPECTRA ANNOUNCES EXPANDED BULK GMP SOLUTIONS.

https://www.biospectra.us/gmp-bulk-solutions

BIOSPECTRA IS PLEASED TO ANNOUNCE THAT WE WILL BE EXHIBITING AT CPHI WORLDWIDE IN FRANKFURT, GERMANY ON NOVEMBER 5-7TH.

https://www.biospectra.us/cphi-worldwide-2019

ANNOUNCING THE OFFICIAL LAUNCH OF BIOSPECTRA’S NEW GMP SODIUM HYDROXIDE SYSTEM!

https://www.biospectra.us/official-launch-of-biospectra’s-new-gmp-sodium-hydroxide-system

BIOSPECTRA ANNOUNCES THE COMMERCIAL LAUNCH OF A NEW, DEDICATED, BULK MANUFACTURING PROCESS FOR GMP GRADES OF SODIUM HYDROXIDE SOLUTIONS.

https://www.biospectra.us/gmp-sodium-hydroxide-solutions

BIOSPECTRA ANNOUNCES ADVANCEMENT IN CARBOHYDRATE PRODUCTION

https://www.biospectra.us/index.php?option=com_content&view=article&id=68

BIOSPECTRA IS PARTICIPATING IN DCAT WEEK, NYC MARCH 18-21ST AND WILL BE LOCATED AT THE LOTTE PALACE, 455 MADISON AVE, SUITE 1203

https://www.biospectra.us/biospectra-is-participating-in-dcat-week-nyc-march-18-21st

BIOSPECTRA WILL BE EXHIBITING AT AAPS PHARMSCI 360
IN WASHINGTON, DC ON NOVEMBER 4-7TH, BOOTH #1911!

https://www.biospectra.us/2018-aaps-pharmsci-360

BIOSPECTRA ANNOUNCES THE LAUNCH OF THREE
“PARENTERAL GRADE” CARBOHYDRATES

https://www.biospectra.us/biospectra-announces-the-launch-of-three-"parenteral-grade"-carbohydrate

BIOSPECTRA ANNOUNCES THE LAUNCH OF LOW-CHLORIDE,
10N SODIUM HYDROXIDE IN BULK

https://www.biospectra.us/biospectra-announces-the-launch-of-low-chloride,-10n-sodium-hydroxide-in-bulk

BIOSPECTRA ANNOUNCES EXPANDED KILO-SCALE SYNTHESIS AND NEW SYNTHETIC ROUTES FOR BIOLOGICAL BUFFERS

https://www.biospectra.us/biospectra-announces-expanded-kilo-scale-synthesis-and-new-synthetic-routes-for-biological-buffers

BIOSPECTRA WILL BE EXHIBITING AT CPHI WORLDWIDE,
OCTOBER 9 -11TH IN MADRID, SPAIN, BOOTH #5A70!

https://www.biospectra.us/biospectra-will-be-exhibiting-at-cphi-worldwide-october-9-11th-in-madrid-spain-booth-5a70

BIOSPECTRA WILL BE EXHIBITING AT PHARMA CHEMOUTSOURCING,
SEPTEMBER 17-19TH IN LONG BRANCH, NJ, BOOTH #40!

http://www.biospectra.us/biospectra-will-be-exhibiting-at-pharma-chemoutsourcing-september-17-19th-in-long-branch-nj-booth-40

DETERMINING THE VALUE OF RE-SHORING DRUG INGREDIENT MANUFACTURING

https://www.biospectra.us/determining-the-value-of-re-shoring-drug-ingredient-manufacturing

BIOSPECTRA TO PRESENT AT CONVENTION FOR PHARMACEUTICAL INGREDIENTS (CPhI) NORTH AMERICA

https://www.biospectra.us/biospectra-to-present-at-convention-for-pharmaceutical-ingredients-cphi-north-america

BIOSPECTRA TO PRESENT AT EXCIPIENTFEST 2017

https://www.biospectra.us/biospctra-to-present-at-excipientfest-2017

EXECUTIVE INTERVIEW: Rick Mutchler, CEO

https://drug-dev.com/executive-interview-biospectra-trusted-reliabe-source-for-intermediates/

PRODUCT SUITABILITY: Dora Meissner, Regulatory Manager

http://www.pharmtech.com/product-suitability-intended-end-use

US MANUFACTURED API TROMETHAMINE NOW AVAILABLE FROM FDA-REGISTERED FACILITY

https://drug-dev.com/us-manufactured-api-tromethamine-from-fda-registered-facility-available-quarter4-2014/

US MANUFACTURED API UREA NOW AVAILABLE FROM FDA-REGISTERED FACILITY

https://drug-dev.com/us-manufactured-api-urea-from-fda-registered-facility-available-q4-2014/

NEW CONTRACT MANUFACTURING FACILITY

http://www.pharmtech.com/biospectra-opens-contract-manufacturing-facility

HEPES, MOPS & MES/Secure Supply Chain

https://drug-dev.com/cgmp-hepes-mops-mes-available-with-full-traceability-secure-supply-chain/

INDUSTRY LEADING CUSTOM MANUFACTURING CAPABILITIES

https://drug-dev.com/biospectra-offers-industry-leading-custom-manufacturing-capabilities/

PHARMA & BIOPHARMA PRODUCT LAUNCH

http://www.contractpharma.com/contents/view_breaking-news/2014-07-24/biospectra-launches-contract-manufacturing-services/